Atherosclerosis

Article	Citations
High incidence of heart failure in elderly patients with diabetes admitted in internal medicine department	122
The emerging landscape of peptide-based inhibitors of PCSK9	106
The effect of LPA Thr3888Pro on lipoprotein(a) and coronary artery disease is modified by the LPA KIV-2 variant 4925G>A	92
The length of telomeres as an original biomarker of the risk of development of cardiovascular diseases and their complications	87
CCL3/CCR5 and CX3CL1/CX3CR1 chemokine interactions are involved in T-cell accumulation in human atherosclerotic plaques	86
Genetic analysis in Russian patients with familial hypercholesterolemia	84
Possible clinical usefulness of polygenic risk scores among patients with established atherosclerotic cardiovascular disease	83
Role of fatty acids in the pathogenesis of ß-cell failure and Type-2 diabetes	73
Statin use is associated with less ST-elevation versus non-ST-elevation myocardial infarction in a nationwide study	71
Targeted proteomics and the presence of carotid plaques in subjects at low cardiovascular disease risk	70
Comparison of cardiovascular prognosis between triglyceride variability and exposure estimate in diabetic patients	65
Common perinatal characteristics and adverse obstetric complications leading to overweight in adolescence: Assessment of independent and shared maternal-offspring pathways	65
Lipid profile assessment as a factor of diabetic nephropathy progression	64
Do triglycerides have an influence on endothelial function detected by Laser Doppler flowmetry?	61
Age- and gender-specific lipid and lipoprotein levels and percentiles from the Thai National Health Examination Survey (NHES-VI) in Thailand	60
Influence of low glycemic index diet on inflammatory state and lipid parameters in patients with atherosclerotic coronary artery disease	60
Endothelial ACKR3 drives atherosclerosis by promoting immune cell adhesion to vascular endothelium	60
Antagonism of miR-148a attenuates the progression of atherosclerosis in APOBTGApobec-/-Ldlr+/- mice	59
Aging accelerates atherosclerosis development in C57BL/6 mice upon PCSK9 overexpression	59
The reliability of coronary artery calcium score in symptomatic patients: Questioning the “power of zero”	56
Does the lipoprotein(A) genotype influence the diagnosis of familial hypercholesterolemia?	55
Genome-wide association study on HDL-mediated cholesterol efflux capacity	54
Genetic risk score for human serum lipidome and its association with angiographic coronary artery disease	53
LATENT TB PREVALENCE AMONG DIABETICS: A SYSTEMATIC REVIEW AND META-ANALYSIS	52
COMMUNITY ENGAGEMENT STRATEGY: ENHANCING VACCINE COVERAGE FOR CARDIOMETABOLIC DISEASE CONTROL	51

ELEVEN YEARS FOLLOW-UP OF 1351 YOUNG FH-INDIVIDUALS IN NORWAY	51
Corrigendum to “The correlation between medial pattern of intracranial arterial calcification and white matter hyperintensities” [Atherosclerosis 381 (2023) 117247]	50
CLINICAL AND GENETIC CHARACTERISTICS OF LATE-ONSET LAL DEFICIENCY IN OMAN	50
TNF-α/STEARATE INDUCED H3K9/18 HISTONE ACETYLATION AMPLIFIES IL-6 EXPRESSION IN ADIPOCYTES	49
THE MOLECULAR BASIS OF DIFFERENT GENETIC LIPID DISORDERS IN LEBANON	47
CARDIOVASCULAR MORBIDITYAMONG TUBERCULOSIS PATIENTS IN INDIA: A CROSS-SECTIONAL STUDY	46
ROLE OF PATIENT ADVOCATES IN SECURING APHERESIS ACCESS IN LEBANON	45
IMPACT OF CALEBIN-A ON KEY DIABETES-ASSOCIATED GENES	45
N-acetylcysteine therapy reduces major adverse cardiovascular events in patients with type 2 diabetes mellitus	44
Association of genetically predicted levels of circulating blood lipids with coronary artery disease incidence	43
Single-cell analysis uncovers osteoblast factor GDF10 as mediator of vascular smooth muscle cell phenotypic modulation associated with plaque rupture in human carotid artery disease	41
Editorial board	40
Bioactive lipids and lipoprotein lipase in epicardial adipose tissue from patients with coronary artery disease: Unfolding a missing link	39
Evolocumab treatment in paediatric patients with homozygous familial hypercholesterolemia: Data from three pooled open-label studies	39
An upregulation of scube 2 expression in type 2 diabetes mellitus with dyslipidemia	39
Reversing the functional- and regenerative capacity of senescent endothelial cells by pharmacological reprogramming	38
Tetrahydroxystilbene glycoside attenuates endothelial dysfunction and obesity-associated hypertension in obese rats: The role of omentin-1	38
Associations of the fatty acids with the concentration of antioxidant enzymes in the blood in men with coronary heart disease	38
Effect of APOC3 inhibition with volanesorsen on hepatic steatosis in patients with severe hypertriglyceridemia	37
IL-21R blockade reduces atherosclerosis development	36
Sex differences of lipoprotein(a) levels and associated risk of morbidity and mortality by age: The Copenhagen general population study	36
Circular decoys sponge miR-21 and miR-146a in senescent vascular cells	36
Size, fatty acid and protein characterization of different populations of extracellular vesicles obtained by sequential centrifugation. An useful tool to dissect their biological properties?	35
The real experience of reaching an extremely low LDL-C level in high risk patients	34
Vulnerable atheromatous plaque stabilization using extracorporeal shock wave- mediated sonoporation therapy- assisted HDL and atorvastatin combination therapy	33
Effect of B-mode ultrasound- guided extracorporeal low- level focused sonotherapy on early stage atherosclerosis regression using color doppler ultrasonography and histopathology	33
Laser- mediated thermal angioplasty of occluded artery accompanied by disulphonated aluminum phthalocyanine - mediated photodynamic therapy combined with catheter- based ruthenium-106 brachytherapy	32
Regulation of interleukin 1Β drives endothelial-to-mesenchymal transition of valve endothelial cells in patients with aortic valve sclerosis	32
The impact of cholesterol lowering drugs on metabolism and epigenetics	32
Atherosclerosis in Brazil: An ecological study	31
Collaboration of clinic and Biobank as an effective model for dyslipidemia research	31
Altered total fecal oxalate-degrading activity is associated with atherosclerosis and systemic inflammation in end-stage renal disease patients	31
A murine model to study neoatherosclerosis after angioplasty: Impact of diabetes on arterial lesion	31
Cysteamine (A lysosomotropic antioxidant) causes regression of atherosclerosis and improves liver and muscle function in LDL receptor deficient mice	30
Quality of life in older patients with obesity and chronic kidney disease	30
Development of new methods for subcellular diagnostics and therapy of atherosclerosis aimed at eliminating dysfunctional mitochondria.	30
The leukocyte-shed short form of plasma soluble CD31 identifies coronary artery disease in patients at low risk: insights from the "Capire" study	30
Relationship between dietary vitamin D intake, obesity, and twenty lipoprotein subclasses: Results from the Kyushu and Okinawa Population Study (KOPS)	29
Analysis of lipid profile in patients on the use of the Aterostop calculator according to body mass index	29
Evaluation of cardiovascular risk factor in a sanitary area of the South of Spain by consultation of the laboratory management system	29
Long-term effects of statins on hemoglobin A1c and fasting blood sugar levels	29
The results of implementing health education in polish ambulatory care on atherosclerosis risk factors	29
Analysis of sterol lipids as carbamates in metabolic syndrome	29
The diagnostic role of paraoxonase 1 and myeloperoxidase as two important hdl-bound enzymes in single- and multi-vessel coronary artery disease	28
Molecular determinism of methicillin resistant Staphylococcus aureus virulence mechanisms in Sepsis	28
Metabolism de-regulation in patients with elevated cardiovascular risk: Intra-vessel alteration and urine reflection	28
Assessment of CYS681Xpolymorphisn of LDL receptor gene’s impact on lipid metabolism in patients with familian hypercholesterolemia	28
Self-reported sleep pattern in hyperlipidemic patients	27
Association between serum angiotensin II to Angiotensin-(1-7) ratio and high density lipoprotein in chronic heart failure	27
Pulse transit interval and cardiovascular risk	27

Statin therapy and lipoprotein(a) levels: A systematic review and meta-analysis	27
Genetic expression and immunofluorescence mapping of NaV1 highlight potential therapeutic targets in anti-inflammatory treatment of aortic valves stenosis	27
Influence of mineral bone disease biomarkers in carotid modeling as a marker of early atherosclerosis in dialysis patients	27
The effect of diabetes mellitus on the expression of potassium channels in the renal artery of the diabetic rats	26
Global Familial Hypercholesterolaemia Studies Collaboration (FHSC)	26
Ballooning overview of liver histopathology of adolescent rat models with type 2 diabetes mellitus induced by high-fat diet and Streptozotocin	26
Assessment of the improvement in perfusion after endovascular intervention by hyperspectral imaging	26
Effect of high- intensity extremely low frequency magnetic field on the intermediate stage atherosclerotic plaque remodeling: Monitored by histopathology and color doppler ultrasonography	26
Silencing of PCSK9 by SIRNA-functionalized RHDL as tool to upregulate LDLR expression in hepatocytes	25
The relationship of asymptomatic hyperuricemia and metabolic syndrome in cardio renal patients	25
Management of significantly elevated lipoprotein(a) in patients without established ASCVD	25
Genetic risk score for carotid atherosclerosis and carotid artery disease: A Russian population-based substudy	25
Methotrexate associated with a lipid core nanoparticle prevented the dilation and dissection of the aortic arch in mice with Marfan syndrome	25
Autonomic regulation of heart rate against the background of highly effective lipid-lowering therapy in persons with postinfarction remodeling	25
Association between level of depression and coronary heart disease, stroke risk and all-cause and cardiovascular mortality	24
Laboratory and instrumental risk factors associated with a sudden cardiac death prone pattern in the general population: Data from the brisighella heart study	24
Coronary computed tomography angiography-derived endothelial shear stress in myocardial bridging	24
Compensatory metabolic responses in ChREBP-deficient brown adipose tissue	24
The role of systemic inflammation in reducing the elasticity of the main arteries in patients with chronic heart failure in combination with obesity	24
“Early detection of cardiovascular risk factors in women following gestational diabetes mellitus: A cohort study”	23
miR-148a-3p: A novel therapeutic candidate modulating angiogenesis and senescence for enhanced myocardial infarction recovery – experimental insights and targets explored	23
Bempedoic acid efficacy and safety in 7,597 non-diabetic patients, with and without metabolic syndrome, from the randomized, placebo-controlled clear outcomes trial	23
The effect of MMP 9, TIMP-1 on the dynamics of cardiac fibrosis in patients with and without coronary artery disease 2 years after renal denervation	23
Statin treatment reduces long-term risk of revision surgery following total hip arthroplasty in osteoarthritis patients: A registry-based study	23
Severe hypertriglyceridemia and its correlation with clinical atherosclerosis and pancreatitis investigated in beta-quantification	23
Residual risk in coronary artery disease: Insights from an observational study	23
Sex differences in the treatment of familial hypercholesterolemia: A systematic review and meta-analysis	22
Machine-learning-based models to predict atherogenic index of plasma range using oculomics and clinic variables in KNHANES for assessing the risk of cardiovascular disease	22
Risk factors for progressive cardiorenal syndrome in patients with chronic kidney disease: The CRIC study	22
Dissecting sexual dimorphism in aortic valve stenosis by proteomics	22
Rare variants in U2-spliceosome genes are involved in autosomal dominant hypercholesterolemia	22
Circulating monocyte phenotype: A novel biomarker of atherosclerosis	22
Low stenosis low volume carotid artery atherosclerotic plaque for early HI-LLT prescription in first grade cardiovascular prevention	21
Circulating large extracellular vesicles from STEMI patients contribute to cardiovascular damage	21
Isolation and culture of murine aortic cells and RNA isolation of aortic intima and media: Rapid and optimized approaches for atherosclerosis research	21
Vascular structural changes in diabetes mellitus patients with chronic kidney disease	21
Comorbidities, frailty, and prognosis in elderly patients with atrial fibrillation and ischemic heart disease: Insights from a tertiary hospital cohort study	21
Hepatic Cdkal1 deletion regulates HDL catabolism and promotes reverse cholesterol transport	21
TREM2 macrophages in adipose tissue and cardiovascular risk	21
The comparative analyses of combined medicine alpha-lipoic acid and zinc with statins in the treatment of dyslipidemia in patients with atherosclerosis	21
Differences in coronary angiographic findings and outcomes between men and postmenopausal women with chest pain	21
Rabies vaccine induced microangiopathy	21
Illness perception in patients with familial hypercholesterolemia	21
Ethnic variations in neutrophil count as predictors of prognosis following acute myocardial infarction	20
Heightened splenic and bone marrow uptake of 18F-FDG PET/CT is associated with systemic inflammation and subclinical atherosclerosis by CCTA in psoriasis: An observational study	20
The impact of gene variants on the thickness and softness of the Achilles tendon in familial hypercholesterolemia	20
Impact of the clinical diagnostic strata of familial hypercholesterolemia on risk stratification among patients with hypercholesterolemia	20
Fgf23 expression increases atherosclerotic plaque burden in male ApoE deficient mice	19
Interplay between epigenetic mechanisms and transcription factors in atherosclerosis	19
Bivariate relation of vascular health and blood pressure progression during childhood	19
Illuminating the full spectrum of APOE variation	19
Bone mineral density and long-term progression of aortic valve and mitral annular calcification: The Multi-Ethnic Study of Atherosclerosis	19
Lipolytic enzymes and free fatty acids at the endothelial interface	19
Soluble CD40 receptor is a biomarker of the burden of carotid artery atherosclerosis in subjects at high cardiovascular risk	19
Coronary artery calcium: The canary in the coal mine	19
Lipotoxicity-driven metabolic dysfunction-associated steatotic liver disease (MASLD)	19
Galectin-9: A novel promoter of atherosclerosis progression	19
Relationship between stress hyperglycemia and worsening heart failure in patients with significant secondary mitral regurgitation	18
Sex differences in LDL-C control in a primary care population: The PORTRAIT-DYS study	18
Added prognostic value of plaque burden to computed tomography angiography and myocardial perfusion imaging	18
The human milk oligosaccharide 3’sialyllactose promotes inflammation resolution and reduces atherosclerosis development.	18
Course of the effects of LDL-cholesterol reduction on cardiovascular risk over time: A meta-analysis of 60 randomized controlled trials	18
The long journey of lipoprotein(a) from cardiovascular curiosity to therapeutic target	18
The value of a negative study	18
Gene set analysis of transcriptomics data identifies new biological processes associated with early markers of atherosclerosis but not with those of osteoporosis: Atherosclerosis-osteoporosis co/multi	18
Sociodemographic determinants of change in cardiovascular health in middle adulthood in a bi-racial cohort	18
Obesity is associated with coronary artery stenosis independently of metabolic risk factors: The population-based SCAPIS study	18
Carotid ultrasound and coronary calcium for the prediction of incident cardiac disease in asymptomatic individuals: A further step towards precision medicine especially in women?	18
Effect of biological sex on human circulating lipidome: An overview of the literature	18
Association of thyroid peroxidase antibody with the RNF213 p.R4810K variant in ischemic stroke/transient ischemic attack	17
COMPUTATIONAL IDENTIFICATION OF SMALL MOLECULES FOR MODULATING ATHEROSCLEROSIS AND NAFLD	17
METABOLOMIC ANALYSIS OF KAZAKH PATIENTS WITH METABOLIC SYNDROME BY GC/MS	17
ACCURACY OF TROPONIN VALUE IN ELDERLY WITH ACUTE CORONARY SYNDROME	17
Transcriptome analysis revealed a two-step transformation of vascular smooth muscle cells to macrophage-like cells	17
LAUNCHOF THE FIRSTHOFH AWARENESS DAY: ADDRESSING UNMET NEEDS	17
CARDIO-PROTECTIVE ROLE OF ROSMARINIC ACID ON ISOPRENALINE INDUCED CARDIAC DYSFUNCTION	17
GENETIC AND BIOCHEMICAL ANALYSIS OF FOUR JAPANESE SEVERE HYPERTRIGLYCERIDEMIA	17
Caspase 8-dependent inhibition of necroptosis prevents plaque necrotic core formation	17
ESTABLISHMENT OF ELISA SYSTEM FOR MODIFIED LDLADIPONECTIN COMPLEX	17
FIRST TIME USE OF LOMITAPIDE IN HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA, UAE	17

UCSCS IN TREATMENT OF T1DM AND T2DM; A META-ANALYSIS	17
Prevalence and prognostic impact of lipid goal attainment and patient adherence to lowering lipid treatment: Data from community Italian setting	16
Interactions between macrophage inhibitor factor and emotional distress in patients with st-segment elevation myocardial infarction	16
Sedentary behaviour and the immune system: Investigating traditional and novel biomarkers in a stroke population.	16
Orbital ischemia syndrome in a patient with carotid artery dissection - Case report	16
Hospitalization features and mortality rates of very high-risk patients with dyslipidemia in Turkey	16
Statin intolerance: What are we overlooking?	16
Genetic variants associated with low-density lipoprotein cholesterol and systolic blood pressure and the risk of recurrent cardiovascular disease in patients with established vascular disease	16
Polymorphic assessment of proprotein convertase subtilisin/kexin type 9 (PCSK9) variant rs11591147 in coronary artery disease subjects from Pakistan	16
Lp(a) level and one-year clinical results of coronary artery bypass surgery due to type of lesion.	16
HIV-infected patients display increased proatherogenic anti-apolipoprotein A1 autoantibodies, inflammatory and metabolomic markers	16
Professor Jeremiah Stamler (1919–2022), “Father of Preventive Cardiology”	16
Response of lipoproteins to a meal tolerance test in patients with type 2 diabetes and hypertriglyceridemia	15
Treatment patterns in atherosclerotic cardiovascular disease (ASCVD-H) and ASCVD-risk equivalent (ASCVD-RE-H) patients, both with hypercholesterolemia, a retrospective real-world database analysis in	15
Nutritional approach in paediatric patients with familial hypercholesterolaemia	15
Protective role for body fat mass in atherogenesis among low cardiovascular risk patients	15
Double trouble: Pathogenic LDLR and SCARB1 variants in the same family	15
Increased values in total cholesterol and LDL cholesterol in “prediabetic” middle-aged and elderly adults with A1C between 5.7 and 6.4%	15
The use of seaweed-derived phytosterols to defeat Alzheimer's Disease	15
Outcome of severe hypertriglyceridemia in hospital practice. A single centre experience from Singapore	15
Optimization and validation of lipoprotein(a) KIV2 isoform measurement in patients with familial hypercholesterolemia	15
Polygenic risk for future coronary artery disease events in familial hypercholesterolemia	15
Safety, adherence and efficacy profile of alirocumab after one year of treatment	15
Protective effect of niclosamide on calcification of aortic valve interstitial cells and its underlying molecular mechanism	15
Dietary-derived antioxidants do not decrease the risk of ischemic stroke: A Mendelian randomization study	15
Association of self-reported health and wellbeing indicators with a positive diagnosis for COVID-19. CARTSESIAN-CY study	14
Association between inflammatory markers levels, inflammatory intake of diet and adherence to the mediterranean diet	14
The ceramide- and phosphatidylcholine- based coronary event risk test2 (CERT2) and cardiovascular mortality in men and women with type 2 diabetes	14
Eicosapentaenoic acid increases omega-3 fatty acid content and reduces inflammatory protein levels in pulmonary endothelial cells during IL-6 exposure	14
Diagnosis, treatment and cardiovascular outcomes in homozygous familial hypercholesterolaemia: A sex-specific analysis	14
Vascular wall damage in atherosclerotic cardiovascular disease; Positive effect of extracellular vesicle-based nanotherapeutics on endothelial dysfunction and its key molecular players	14
The effect of iatrogenic hypothyroidism on lipoprotein subfractions and serum paraoxonase activity in patients with differentiated thyroid cancer	14
Cardiopulmonary exercise test alterations in young smokers with obesity	14
Small LDL subfractions are associated with coronary atherosclerosis	14
Single-cell transcriptional and epigenomic dissection of human heart in health and coronary artery disease reveals cell-type-specific driver genes and pathways	14
Mature natural killer type 2 cells and experimental atherosclerosis	14
Treatment of vulnerable plaque using combined high-density lipoprotein and pentostatin- loaded microbubbles- mediated shock wave sonoporation therapy: Evaluation with positron emission tomography imag	14
Epicardial adipose tissue and metabolic markers in dominican type 2 diabetics with preserved cardiac function	14
Plasma concentrations of apolipoproteins and incident cardiovascular diseases in patients with type 2 diabetes	14
High lipoprotein(A) increases risk of peripheral arterial disease, abdominal aortic aneurysms, and major adverse limb events	14
Assessment of atherosclerotic lesions of the carotid arteries depending on the smoking index in patients with coronary artery disease	14
Evidence of proatherogenic inflammation in vascular endothelium of caviae porcellous infected with helicobacter pylori and exposed to high fat diet	14
P-selectin as a modulator of fibrin clot properties in patients treated with high-dose statins	14
Protein alterations in VSMCS reveal a defective repairment capacity in thoracic aortic aneurysm associated to BAV	13
Arterial stiffness and glycometabolic control in older patients with type 2 diabetes	13
Hyperlipoproteinemia(a) in familial hypercholesterolemia	13
In patients with cardiovascular disease and heart failure dental state (tooth loss) may exacerbate inflammatory syndrome	13
Serum fetuin-A and retinol-binding protein 4 correlate with lipoprotein subfractions in obese and lean non-diabetic subjects	13
Infectious agent as a trigger mechanism of atherosclerosis and сerebrovascular diseases	13
Lipid metabolism disorders in patients with arterial hypertension and gout	13
An innovative berberine formulation is able to improve bbr bioavailability and the lipid and glycemic profile in HFD-fed mice	13
Editorial board	13
Post-prandial analysis of fluctuations in the platelet count and platelet activity in patients with the familial chylomicronemia syndrome	13
Intermediate stage atherosclerosis regression, using combination atorvastatin loaded microbubbles- mediated focused ultrasound sonoporation therapy and lipid based encapsulated gold nanoparticles- med	13
VEGF-A levels and G634c gene polymorphism as a predictor of adverse outcomes in patients with STEMI	13
Hepatic fibrosis is associated with higher in-hospital mortality in patients admitted with acute ischemic stroke	13
Сomparability of quantitative parameters of significant and insignificant stenoses in non-coronary arteries in males with multifocal atherosclerosis	13
Intermediate stage atherosclerosis regression, using protoporphyrin ІX-loaded pesda microbubbles- mediated B-mode ultrasound- guided extracorporeal focused low- level confocal dual pulse electrohydrau	13
Chronic kidney disease induced atherosclerosis: The regulatory role of mIR-26b	13
A case with anti-GPIHBP1 antibody positive autoimmune hyperchylomicronemia accompanied with idiopathic thrombocytopenic purpura	13
Region-specific lipid markers of human carotid atherosclerosis plaque outcome detected by matrix-assisted laser desorption/ionization mass spectrometry imaging	13
Investigation of the antioxidant and anti-inflammatory potency of Echinacea angustifolia extract	13
Implications of supermarket and street markets access for the metabolic syndrome in the Athens metropolitan area	13
Heteroplasmy of atherosclerosis-associated mitochondrial DNA mutations and its effects on respiration and viability of cybrids	13
Effect of lipid- based encapsulated docetaxel nanoparticles- mediated B- mode ultrasound- guided focused low- level confocal dual pulse electrohydraulic shock wave therapy accompanied by intravenous m	13
Editorial Board	12
High and low levels of serum Sirtuin6 in patients with acute ischemic stroke	12
Polymorphism of DNA repair genes (APEX1 T444G RS1130409) in obese gout patients in the male population of the trans-baikal territory in Russia	12
Non-esterified fatty acids and risk of peripheral artery disease in older adults: The cardiovascular health study	12
Humoral responses against HDL are linked to lipoprotein traits, atherosclerosis, inflammation and pathogenic pathways during early arthritis stages	12
The condition of the main arteries in patients with chronic heart failure and diabetes mellitus	12
New method of calculating low density lipoprotein cholesterol using Korea National Health and Nutrition Examination Survey (KNHANES) and its validation	12
Lysosomal acid lipase (LAL) deficiency alters immune cells distribution in mice and humans	12
The importance of cascade screening of familial hypercholesterolemia in routine clinical practice	12
Liver-humanized mice fed a NASH-diet are an advanced model to study cardiometabolic diseases	12
LPA genotypes and haplotypes influence lipoprotein(a) levels but not arterial wall properties, in stable post-coronary event patients with very high lipoprotein(a) levels	12
Frequency of variants causing familial hypercholesterolaemia (FH) and impact on LDL-C concentration in individuals of South Asian and African ancestry in the UK Biobank	12
A historical view of estrogen effect on arterial endothelial healing: From animal models to medical implication	12
Ensemble machine learning for screening cardiovascular diseases in electronic health records	12
Dietary pattern of elderly people living in the rural area of Mortugaba (BA), Brazil	12
Myeloid cannabinoid receptor CB1 deficiency limits macrophage proliferation and atherosclerosis in a sex-specific manner	12
Pediatric reference values for non-fasting lipids in French-Canadian children	12
The patient will see you now: Patient preferences for lipid clinic reviews in a COVID era	12
Modern methods for diagnosing and assessment of risk factors for atherosclerosis using the “Aterostop” calculator	12
Association of parental obesity and body mass index in children of patients with early ischemic heart disease	12
Compliance of heterozygous familial hypercholesterolemia patients: 5-years follow-up of the Russian familial hypercholesterolemia registry	12
Positivity of statin-associated muscle symptoms – Clinical index in a hypertensive population candidated to lipid-lowering therapy but not taking statins	12
Granzyme B+ CD4+ T cells associate with an unstable plaque phenotype in advanced human atherosclerosis	12
Associations of carotenoids, vitamin A and mortality: The Ludwigshafen Risk and Cardiovascular Health (LURIC) study	12
Impact of circulatory microRNA-126 &122 in severity of coronary artery disease correlation with small dense LDL: A case control study	11
Inflammation in COVID-19 is linked to pulmonary embolism and/or vascular tree-in-bud in hospitalized patients. The university hospital of Ioannina COVID-19 Registry, NCT05534074	11
The role of antioxidant intake in weight status of children in early adolescence	11
A novel cardiovascular-kidney-metabolic syndrome mouse model with inducible HFrEF and atherosclerosis	11
The role of antiphospholipid antibodies in the onset of myocardial infarction	11
Association of blood lipid profile with 20-year (2002-2022) incidence of cardiovascular disease: The ATTICA study	11